Adam Logal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Logal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Logal. Adam Logal is Interim CFO, CAO and Treasurer in Aviragen Therapeutics, Inc. ($NABI) and Sr. Vice President, CFO in Opko Health, Inc. ($EXEG) and Director in VBI Vaccines Inc/BC ($VBIV) and Director in Xenetic Biosciences, Inc. ($XBIO).
Latest Insider Trading Transactions of Adam Logal
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EXEG, VXRT, VBIV, XBIO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2021 | EXEG | OPKO HEALTH, INC. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 4.81 | 350,000 | 1,683,500 | 350,000 | |
Dec 08 2020 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 1.10 | 25,000 | 27,500 | 25,000 | |
Jun 08 2020 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 2.27 | 350,000 | 794,500 | 350,000 | |
Dec 06 2019 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 1.31 | 25,000 | 32,750 | 25,000 | |
Jul 03 2019 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 2.47 | 250,000 | 617,500 | 250,000 | |
May 10 2019 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 2.04 | 3,150 | 6,426 | 179,162 | 176 K to 179.2 K (+1.79 %) |
May 10 2019 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 2.04 | 100 | 204 | 176,012 | 175.9 K to 176 K (+0.06 %) |
Nov 30 2018 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 3.05 | 25,000 | 76,250 | 25,000 | |
Jun 22 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 4.46 | 300,000 | 1,338,000 | 300,000 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
Jun 12 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | M | 3.43 | 75,000 | 257,250 | 0 | |
Jun 12 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Payment of Exercise | F | 4.26 | 63,946 | 272,410 | 175,912 | 239.9 K to 175.9 K (-26.66 %) |
Jun 12 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | M | 3.43 | 75,000 | 257,250 | 239,858 | 164.9 K to 239.9 K (+45.49 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 3.40 | 50 | 170 | 164,858 | 164.8 K to 164.9 K (+0.03 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 3.40 | 2,015 | 6,841 | 164,808 | 162.8 K to 164.8 K (+1.24 %) |
Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
Oct 13 2017 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 2.95 | 6,250 | 18,438 | 25,000 | |
Oct 13 2017 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 2.95 | 6,250 | 18,438 | 18,750 | |
Oct 13 2017 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 2.95 | 6,250 | 18,438 | 12,500 | |
Oct 13 2017 | XBIO | Xenetic Bioscience ... | Logal Adam | Director | Option Exercise | A | 2.95 | 6,250 | 18,438 | 6,250 | |
Sep 18 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 6.03 | 1,500 | 9,045 | 162,793 | 161.3 K to 162.8 K (+0.93 %) |
Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Buy | M | 0.00 | 12,500 | 0 | 25,000 | 12.5 K to 25 K (+100.00 %) |
Mar 31 2017 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | A | 3.79 | 12,500 | 47,375 | 12,500 | |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | M | 2.36 | 75,000 | 177,000 | 0 | |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | M | 0.56 | 189,207 | 105,956 | 0 | |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 8.07 | 112,975 | 911,674 | 161,293 | 274.3 K to 161.3 K (-41.19 %) |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Payment of Exercise | F | 7.92 | 35,728 | 282,966 | 274,268 | 310 K to 274.3 K (-11.53 %) |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | M | 2.36 | 75,000 | 177,000 | 309,996 | 235 K to 310 K (+31.92 %) |
Mar 15 2017 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | M | 0.56 | 189,207 | 105,956 | 234,996 | 45.8 K to 235 K (+413.21 %) |
Apr 01 2016 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 10.41 | 250,000 | 2,602,500 | 250,000 | |
Sep 15 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 9.95 | 900 | 8,955 | 45,789 | 44.9 K to 45.8 K (+2.00 %) |
Sep 15 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | P | 9.95 | 100 | 995 | 44,889 | 44.8 K to 44.9 K (+0.22 %) |
Mar 19 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | A | 14.42 | 250,000 | 3,605,000 | 250,000 | |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | M | 1.65 | 35,000 | 57,750 | 0 | |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Option Exercise | M | 1.16 | 60,000 | 69,600 | 0 | |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 14.65 | 1,500 | 21,968 | 44,789 | 46.3 K to 44.8 K (-3.24 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 14.64 | 38,888 | 569,320 | 46,289 | 85.2 K to 46.3 K (-45.66 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 14.62 | 500 | 7,308 | 85,177 | 85.7 K to 85.2 K (-0.58 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 14.61 | 576 | 8,415 | 85,677 | 86.3 K to 85.7 K (-0.67 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Sell | S | 14.56 | 24 | 349 | 86,253 | 86.3 K to 86.3 K (-0.03 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Payment of Exercise | F | 14.60 | 3,956 | 57,758 | 86,277 | 90.2 K to 86.3 K (-4.38 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | M | 1.65 | 35,000 | 57,750 | 90,233 | 55.2 K to 90.2 K (+63.37 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Payment of Exercise | F | 14.60 | 4,767 | 69,598 | 55,233 | 60 K to 55.2 K (-7.94 %) |
Mar 13 2015 | EXEG | Opko Health, Inc. | Logal Adam | Sr. Vice President, ... | Buy | M | 1.16 | 60,000 | 69,600 | 60,000 | 0 to 60 K |
May 16 2006 | NABI | Aviragen Therapeut ... | Logal Adam | Interim CFO, CAO an ... | Option Exercise | A | 6.30 | 20,000 | 126,000 | 20,000 |
Page: 1